Back to Search
EVAN BARNATHAN, M.D.
M.D.
Family Medicine Physician
NPI: 1558773994IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD21492(ME)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
TUFTS UNIVERSITY SCHOOL OF MEDICINE
Class of 2014
Research & Publications (20)
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.
PMID 19539361·Lancet·2009
3-trial
Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation.
PMID 19395578·Chest·2009
4-observational
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.
PMID 19136369·Am J Respir Crit Care Med·2009
2-rct
Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial.
PMID 18772451·Stroke·2008
4-observational
Facilitated PCI in patients with ST-elevation myocardial infarction.
PMID 18499565·N Engl J Med·2008
4-observational
Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems.
PMID 18429644·Am J Clin Dermatol·2008
8-other
Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
PMID 18157932·Mol Immunol·2008
7-preclinical
Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
PMID 18032739·Stroke·2008
3-trial
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.
PMID 17643581·Am Heart J·2007
8-other
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.
PMID 17290043·Am J Respir Crit Care Med·2007
4-observational
Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
PMID 17070148·Am Heart J·2006
2-rct
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
PMID 16840744·Am J Respir Crit Care Med·2006
3-trial
Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis.
PMID 15831694·J Epidemiol Community Health·2005
3-trial
Antibodies to platelet factor 4/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromes.
PMID 15815878·J Thromb Thrombolysis·2004
4-observational
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS.
PMID 15342168·Eur Heart J·2004
3-trial
Role of anti-PF4/heparin antibodies in recurrent thrombotic events after acute coronary syndromes.
PMID 15282657·Semin Thromb Hemost·2004
3-trial
Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion.
PMID 14963184·J Vasc Interv Radiol·2004
4-observational
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.
PMID 14760324·Am Heart J·2004
3-trial
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
PMID 12847065·Circulation·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 22 BRAMHALL ST
PORTLAND, ME 04102 - Phone
- (207) 662-0111
Quick Facts
- NPI
- 1558773994
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile